Journal of Autacoids Open Access

  • Journal h-index: 4
  • Journal CiteScore: 1.06
  • Journal Impact Factor: 1.37
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Reach us +32 25889658

Opinion - (2024) Volume 5, Issue 2

Neurokinins: Diverse Peptides Influencing Neurotransmission, Pain, and Immune System Activity
John Holloway*
 
Departments of Pharmacology, Marshall University School of Medicine, USA
 
*Correspondence: John Holloway, Departments of Pharmacology, Marshall University School of Medicine, USA, Email:

Received: 29-May-2024, Manuscript No. JAC-24-20935 ; Editor assigned: 31-May-2024, Pre QC No. JAC-24-20935 (PQ); Reviewed: 14-Jun-2024, QC No. JAC-24-20935; Revised: 19-Jun-2024, Manuscript No. JAC-24-20935 (R); Published: 26-Jun-2024, DOI: 10.35841/jac.5.2.16

Introduction

Neurokinins are a family of neuropeptides that include Substance P, Neurokinin A (NKA), and neurokinin B (NKB), playing critical roles in the nervous and immune systems. These peptides are part of the tachykinin family and are synthesized and released by neurons in response to various stimuli. Neurokinins act primarily through their specific G-protein coupled receptors: Neurokinin-1 (NK1), Neurokinin-2 (NK2), and Neurokinin-3 (NK3), each associated with distinct physiological effects. Substance P, the most studied neurokinin, is involved in pain perception, promoting inflammatory responses, and regulating mood. Neurokinin A and B, while less studied, also contribute to important functions. NKA is known for its role in gastrointestinal motility and smooth muscle contraction, whereas NKB influences reproductive functions and neuroendocrine regulation. Neurokinins’ diverse actions in pain modulation, immune response, and physiological regulation make them significant in both health and disease.

Description

Neurokinins, including Substance P, Neurokinin A (NKA), and Neurokinin B (NKB), are neuropeptides that play pivotal roles in the nervous and immune systems. These peptides belong to the tachykinin family and exert their effects through specific G-protein coupled receptors: NK1, NK2, and NK3. Substance P, the most well-known neurokinin, is crucial in transmitting pain signals and modulating inflammatory responses. By binding to the NK1 receptor, Substance P facilitates pain perception and contributes to the development of chronic pain conditions. It also enhances immune cell activation and increases vascular permeability, playing a significant role in inflammatory and allergic reactions. Neurokinin A is involved in gastrointestinal motility and smooth muscle contraction, affecting digestive processes and respiratory function. Neurokinin B, on the other hand, is essential for regulating reproductive functions and neuroendocrine activities. Dysregulation of neurokinin signaling can lead to various disorders, including chronic pain, asthma, irritable bowel syndrome, and mood disorders. Research into neurokinins’ mechanisms and actions provides insights into their roles in health and disease, highlighting their potential as therapeutic targets. Developing treatments that modulate neurokinin activity could offer new approaches for managing these conditions and improving patient quality of life.

Conclusion

In conclusion, neurokinins, comprising Substance P, neurokinin A (NKA), and neurokinin B (NKB), are vital neuropeptides that significantly impact pain transmission, inflammation, and various physiological functions. Through their specific receptors-NK1, NK2, and NK3-neurokinins influence pain perception, immune responses, gastrointestinal motility, and reproductive health. Their involvement in chronic pain, inflammatory diseases, and mood disorders underscores their importance in both health and disease. Dysregulation of neurokinin signaling can lead to a range of disorders, highlighting the need for targeted therapies. By advancing our understanding of neurokinins’ mechanisms, researchers can develop novel treatments that effectively manage conditions such as chronic pain, asthma, and gastrointestinal disorders. Therapeutic strategies aimed at modulating neurokinin activity have the potential to offer new solutions for improving patient outcomes and quality of life. Continued research and innovation in this area will be crucial for translating these insights into effective clinical therapies.

Acknowledgement

None.

Conflict Of Interest

The author’s declared that they have no conflict of interest.

Citation: Holloway J (2024) Neurokinins: Diverse Peptides Influencing Neurotransmission, Pain, and Immune System Activity. Autacoids J. 5:16.

Copyright: © 2024 Holloway J. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited